It has been reported that diabetic AD-MSCs and high glucose-treated control AD-MSCs displayed enhanced stemness by upregulation of pluripotent genes Sox-2, Oct-4, and Nanog through the stimulation of intracellular ROS synthesis, despite decreased proliferation [88]. The gene discussed is POU5F1; the disease is Alzheimer disease.